Medical Ultrasound Devices: Technologies and Global Markets

Report Highlights

The global market for medical ultrasound devices is expected to reach $9.9 billion by 2021 from $7.3 billion in 2016, rising at a compound annual growth rate (CAGR) of 6.4% from 2016 through 2021.

Report Includes

• An overview of the global markets for medical ultrasound devices
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
• Coverage of diagnostic acoustic sensors and opportunities in radiology, cardiology, obstetrics/gynecology, surgical, urology, musculoskeletal, and endoscopic areas
• Identification of the basic components of the technology
• Trends in the healthcare industry affecting the demand for sensors
• A breakdown of technological developments and R&D
• Profiles of leading manufacturers
• Patent analysis

Report Scope

This BCC Research report focuses on the global market for medical ultrasound devices by geographic region and by market segment and provides an in-depth discussion and an analysis of the clinical applications of ultrasound equipment and a review of new and developing technology platforms.

This report also examines companies that are actively developing and marketing medical ultrasound devices around the world. Detailed tables and charts with sales forecasts and market share data are also included.

Medical ultrasound devices can be segmented by application/therapeutic area, i.e.:

• Radiology/general imaging.
• Cardiology.
• Obstetrics/gynecology.
• Vascular.
• Urology.
• Breast imaging.
• Anesthesiology.
• Thyroid imaging.
• Other applications (includes hepatology, emergency care and ophthalmics, among others).

The ultrasound market is also segmented by technology, i.e.:

• Diagnostic ultrasound.
• Two-dimensional (2-D) ultrasound.
• 3-D and 4-D ultrasound.
• Doppler ultrasound.

• Therapeutic ultrasound.
• High-intensity focused ultrasound (HIFU).
• Extracorporeal shockwave lithotripsy.

Analyst Credentials

PAUL TAYLOR is an independent market researcher and analyst focused on the medical industry working on projects for over 20 years for a variety of prestigious clients including Agilent & Philips Medical Systems, Biomatrix, Inc (Genzyme Corporation), GE Medical Systems (Multiple Projects), Amersham Pharmacia Biotech Limited, Amersham Pharmacia Biotech Limited and Baxter Heathcare. He previously worked for multinational medical device and pharmaceutical companies including Bristol-Myers Squibb, Johnson & Johnson and Pfizer on developing and implementing strategic business and marketing plans. His predictive analytics knowledge and models of market research data have been used for biopharmaceutical and biotechnology clients. He has a bachelor's degree and Ph.D. degree in biochemistry from the University of Liverpool and an MBA degree for Oxford Brookes University.